PA
WHWK

Parallel Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Parallel Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28 Hold
8
– – ﹤0.01% 3808
2025
Q4 		$19 Hold
8
– – ﹤0.01% 3598
2025
Q3 		$15 Hold
8
– – ﹤0.01% 3532
2025
Q2 		$15 Hold
8
– – ﹤0.01% 3518
2025
Q1 		$14 Hold
8
– – ﹤0.01% 3490
2024
Q4 		$25 Hold
8
– – ﹤0.01% 3496
2024
Q3 		$16 Hold
8
– – ﹤0.01% 3378
2024
Q2 		$12 Sell
8
-161,188
-100% -$299K ﹤0.01% 3297
2024
Q1 		$377K Buy
161,196
+154,788
+2,416% +$298K 0.01% 619
2023
Q4 		$12.9K Sell
6,408
-50
-0.8% -$210 ﹤0.01% 2178
2023
Q3 		$31.3K Buy
6,458
+50
+0.8% +$291 ﹤0.01% 1625
2023
Q2 		$43.8K Hold
6,408
– – ﹤0.01% 1468
2023
Q1 		$46.4K Hold
6,408
– – ﹤0.01% 1405
2022
Q4 		$82.2K Hold
6,408
– – ﹤0.01% 1068
2022
Q3 		$91K Hold
6,408
– – ﹤0.01% 1012
2022
Q2 		$79K Hold
6,408
– – ﹤0.01% 1052
2022
Q1 		$111K Hold
6,408
– – ﹤0.01% 953
2021
Q4 		$155K Hold
6,408
– – 0.01% 840
2021
Q3 		$188K Buy
6,408
+6,400
+80,000% +$195K 0.01% 745
2021
Q2 		$0 Hold
8
– – ﹤0.01% 3090
2021
Q1 		$0 Hold
8
– – ﹤0.01% 2920
2020
Q4 		$0 Buy
+8
New +$171 ﹤0.01% 2754

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Parallel Advisors's WHWK Position: Q1 2026 in Review

Parallel Advisors held its Whitehawk Therapeutics (WHWK) position steady in Q1 2026 at 8 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #3808.

Parallel Advisors first reported a position in WHWK in Q4 2020 and has held it in 22 quarters since. The position peaked at $377K in Q1 2024. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Parallel Advisors held 8 shares of Whitehawk Therapeutics worth $28 as of Q1 2026.
  • Parallel Advisors left its Whitehawk Therapeutics share count unchanged in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3808 holding.
  • Parallel Advisors first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Parallel Advisors's Whitehawk Therapeutics position peaked at $377K in Q1 2024.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.